Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity

M. M. Schoonheim; L. E. Jonkman; A. J. Eijlers; K. A. Meijer; J. Killestein; J. J. Geurts

Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity

M. M. Schoonheim, L. E. Jonkman, A. J. Eijlers, K. A. Meijer, J. Killestein, J. J. Geurts

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	858-858
Journal	European journal of neurology
Volume	26
Publication status	Published - Jul 2019

Cite this

@article{a62c7cc61f5b45cf94803eedcd927825,

title = "Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity",

author = "Schoonheim, {M. M.} and Jonkman, {L. E.} and Eijlers, {A. J.} and Meijer, {K. A.} and J. Killestein and Geurts, {J. J.}",

year = "2019",

month = jul,

language = "English",

volume = "26",

pages = "858--858",

journal = "European journal of neurology",

issn = "1351-5101",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity

AU - Schoonheim, M. M.

AU - Jonkman, L. E.

AU - Eijlers, A. J.

AU - Meijer, K. A.

AU - Killestein, J.

AU - Geurts, J. J.

PY - 2019/7

Y1 - 2019/7

M3 - Meeting Abstract

SN - 1351-5101

VL - 26

SP - 858

EP - 858

JO - European journal of neurology

JF - European journal of neurology

ER -